Biomarker ID | 1723 |
PMID | 30672309 |
Year | 2019 |
Biomarker | Zn/PSA |
Biomarker Basis | Concentration Based (ng/mL) |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs No Prostate Cancer |
Type of Biomarker | Diagnostic |
Cohort | 480 patients were selected for the study. 361 had negative biopsies and 119 had positive biopsies |
Senstivity | 56.3% |
Specificity | 70.3% |
AUC | 0.702 (95% CI: 0.659-0.742) |
Accuracy | NA |
Level Of Significance | p=0.0001 |
Method Used | electrochemiluminescence immunoassay |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |